Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Nicorandil on Atherosclerosis Risk in Patients With Rheumatoid Arthritis: A Randomized Controlled Clinical Trial.

NCT07800351 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07800351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07800351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Nicorandil on Atherosclerosis Risk in Patients With Rheumatoid Arthritis: A Randomized Controlled Clinical Trial.
Lead sponsor
Tanta University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
April 30, 2027
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, rheumatoid arthritis (ra